Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695655 · ClinicalTrials.gov registry record
Neovascularization Patterns in Corneal Graft Rejection
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 44
- Enrollment target
NCT01695655: Completed study, sponsored by University of Michigan.
NCT01695655 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01695655 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Corneal transplantation is the most commonly performed human tissue transplant worldwide. Over 40,000 corneal transplants occur in the US each year. . This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics that worsen the prognosis for graft survival. We will test the hypothesis that specific characteristics of CN are prognostic for corneal allograft rejection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2007-11 |
| Est. Completion | 2016-12 |
What the finished NCT01695655 record still lists
NCT01695655 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01695655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01695655 about?
NCT01695655 is a clinical study titled "Neovascularization Patterns in Corneal Graft Rejection". Corneal transplantation is the most commonly performed human tissue transplant worldwide. Over 40,000 corneal transplants occur in the US each year. . This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics t...
What is the current status of trial NCT01695655?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2007-11. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01695655?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia